The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is an autoimmune demyelinating disease and a common cause of neurological disability in young adults. The modest heritability of MS reflects complex genetic effects and multifaceted gene-environment interactions. The human leukocyte antigen (HLA) region is the strongest susceptibility locus for MS, but a genome-wide association study recently identified new susceptibility genes. Progress in high-throughput genotyping and sequencing technologies and a better understanding of the structural organization of the human genome, together with powerful brain-imaging techniques that refine the phenotype, suggest that the tools could finally exist to identify the full set of genes influencing the pathogenesis of MS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“do not seem to have a significant genetic component”
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439 · cited 1×
“It is of considerable interest that a recent clinical trial of an anti-B-cell therapy in MS showed marked effects in reducing bursts of focal inflammatory disease activity, establishing the vital importance of B cells as triggers of MS attack”
BackgroundSelf-citationWacholder, S., Chanock, S., Garcia-Closas, M., El ghormli, L., & Rothman, N. (2004) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djh075 · Cited by 1,754
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Research works printed but not linked: 3
- Hauser, S. L. & Goodin, D. S. in Harrison's Principle of Internal Medicine 17th edn (eds Fauci, A. D. et al.) 2611–2620 (McGraw Hill, New York, 2008).
- Kantarci, O. H. et al. Men with MS transmit the disease more often to their children then women: the Carter effect. Mult. Scler. 10, S203 (2004).
- Anderson, A. & Karlsson J. Genetic of experimental autoimmune encephalomyelitis in the mouse. Arch. Immunol. Ther. Exp. (Warz) 52, 316–325 (2004).
Cited by
Items 301–347 of 347
The genetics of multiple sclerosis
Oksenberg, J. R., Baranzini, S. E., & Hauser, S. L. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986.007
Self-citationNaci, H., Fleurence, R., Birt, J. A., & Duhig, A. (2009) · Value in Health · doi:10.1016/s1098-3015(10)74034-1
Morón, D. G., Kauffman, M., Garcea, O., & Villa, A. M. (2010) · Neurología Argentina · doi:10.1016/s0325-0938(10)70006-4
Acute Demyelination In Children: Predicting Pediatric Multiple Sclerosis Manifestation
Hoffjan, S., & Epplen, J. T. (2011) · Future Neurology · doi:10.2217/fnl.11.41
Heterogeneity in multiple sclerosis; a bio-marker approach
Zwemmer, J. (2011) · Pure Amsterdam UMC
Ben-Fredj, N. (2012) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000122
“Multiple sclerosis is a chronic demylinating disease of the human central nervous system of a still unknown etiology; however, it has been suggested to be affected by an interaction between genetic, environmental and geographical factors [39,40].”
BackgroundVALIDACIÓ D'UN ESTUDI D'EXÒMICA EN UNA FAMÍLIA AFECTADA D'ESCLEROSI MÚLTIPLE
Baena, A. F. (2015) · DUGiDocs (Universitat de Girona)
Bettencourt, A., SILVA, A. C. F. D., Costa, P., & da Silva, B. M. (2012)
Investigating the potential regulation of Asic2 by microRNAs
Cole, H. R. (2012) · UEA Digital Repository (University of East Anglia)
Characterizing association parameters in genetic family-based association studies
Böhringer, S. (2009) · Technische Universität Dortmund Eldorado (Technische Universität Dortmund) · doi:10.17877/de290r-8253
“[74]).”
Systems Medicine of Autoimmune Diseases
Fernández, J. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803302-9.00009-9
Carmichael, D. A. (2015) · ERA
PATHOGENIC AND THERAPEUTIC ASPECTS OF INTRATHECAL IMMUNE RESPONSES IN MULTIPLE SCLEROSIS
Hestvik, A. L. K. (2009) · NORA - Norwegian Open Research Archives
Helminth Immunoregulation and Multiple Sclerosis Treatment
Correale, J. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-29716-3_17
Immunogenetics of Neurological Disease
Elangovan, R. I., Ramagopalan, S. V., & Dyment, D. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00003-6
Neurohormetic Properties of the Phytochemical Resveratrol
Holme, A. L., & Pervaiz, S. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch21
Shen, P., Hilgenberg, E., Lino, A. C., Dang, V. D., Ries, S., Sakwa, I., & Fillatreau, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00013-8
Monitoring of multiple sclerosis
Goertsches, R. H., Hecker, M., & Zettl, U. K. (2008)
Dopico, L. (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170626ald
Rossato, C. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2017.tde-08052017-153614
Sclérose en plaques et uvéites
Stathopoulos, C. (2010) · Elsevier eBooks · doi:10.1016/b978-2-294-71107-7.50032-9
Kortikale Demyelinisierung bei entzündlichen, neoplastischen und metabolischen ZNS-Erkrankungen
Wozniak, J. Z. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7126
Gross, R., & Jager, P. L. D. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-860-7_4
Mohammadi-Kordkhayli, M., Sahraian, M. A., Ghorbani, S., Mansuri, F., Talebi, F., Noorbakhsh, F., & Saboor-Yaraghi, A. A. (2021) · Research Square · doi:10.21203/rs.3.rs-1091850/v1
Immunomodulating, Neuroprotective and Regenerative Modalities in Multiple Sclerosis Management
Chan Mike, K. S., Michele, Z., Tulina, D., Kour Anam, K., Cher, R. L., Moya, R. L., & Fah Michelle, W. B. (2020) · International Journal of Neurodegenerative Disorders · doi:10.23937/2643-4539/1710017
“Genetic factors may play a major role [9], whereas other studies have indicated a correlation between pathogenic infections and the development of the disease [10].”
BackgroundAuffray, C. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.3133965.3012054
Transcriptome Profiling in Autoimmune Diseases
Collares, C. V. A., & Donadi, E. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-87821-4_11
Morón, D. G., Kauffman, M., Garcea, O., & Villa, A. M. (2010) · Neurología Argentina · doi:10.1016/s1853-0028(10)70023-9
(2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1781-5.00022-2 · Cited by 1
The profiling and imaging of sterol molecules in the human brain
Griffiths, L. (2023) · Cronfa (Swansea University) · doi:10.23889/suthesis.62587
İNBAŞI, E. G., Alim, N. E., & Yetkin, M. F. (2023) · İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi · doi:10.33715/inonusaglik.1379379
Barjui, S. P., Shahrakei, Z. F., & Jivad, N. (2023) · Epidemiology and Health System Journal · doi:10.34172/ehsj.26068 · Cited by 1
Rostami, F., Vakilian, A., Esmaeilian, S., Jalali, N., & Tahernia, H. (2024) · Research Square · doi:10.21203/rs.3.rs-3851895/v1 · Cited by 3
Pediatric multiple sclerosis and acute disseminated encephalomyelitis
O’Neill, K. A., Fernandez-Carbonell, C., Maletić‐Savatić, M., & Krupp, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00073-4
K., A., Mohammed, H. N., Al-Samarrai, S. S. M., & Samer, A. J. A. (2025) · Regulatory Mechanisms in Biosystems · doi:10.15421/0225130 · Cited by 1
Fashina, I. A., McCoy, C. E., & Furney, S. J. (2024) · Figshare · doi:10.6084/m9.figshare.26579078
Fashina, I. A., McCoy, C. E., & Furney, S. J. (2024) · Figshare · doi:10.6084/m9.figshare.26579081
Okolicsanyi, R. K., Bluhm, J., Miller, C., Griffiths, L. R., & Haupt, L. M. (2020) · Figshare · doi:10.6084/m9.figshare.12291518
Thétiot, M. (2018) · theses.fr (ABES) · doi:10.70675/4fd006d4z6c0ez4fe8zbcd0z0df8b8ef8d85
Extracellular vesicles in neurodegenerative diseases
Singh, G., Prasad, S., Singh, C., & Singh, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36641-3.00008-5
Multiple sclerosis and the limits of classical autoimmune theory
Hedström, A. K., & Piehl, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1849080
Eckert, S. P., Funez-dePagnier, G., Hicar, M. D., & Weinstock‐Guttman, B. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2026.2713626
“Among the genetic risk factors for MS, the human leukocyte antigen (HLA)-DR15 may account for up to 60% of the genetic risk [41].”
Athouf, D. A. (2026) · Indonesian Journal of Microbiology · doi:10.47134/ijm.v3i1.6183
Transplantation of Stem Cells and Their Derivatives in the Treatment of Multiple Sclerosis
Larsen, E. C., & Duncan, I. D. (2009) · Springer eBooks · doi:10.1007/978-90-481-3040-5_8
Metadata
- Authors
- Oksenberg, J. R., Baranzini, S. E., Sawcer, S., & Hauser, S. L.
- Affiliations
- University of California, San Francisco (US)
- University of Cambridge (GB)
- Corresponding author
- Oksenberg, Jorge R.
- Hauser, Stephen L.
- Venue
- Nature Reviews Genetics
- Published
- 2008-06-10
- Volume
- 9
- Issue
- 7
- Pages
- 516-526
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W1991500494
- Cited by
- 347
- References
- 125
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 7 · 2020: 11 · 2019: 7 · 2018: 10 · 2017: 15 · 2016: 15 · 2015: 22 · 2014: 27 · 2013: 20 · 2012: 22
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, genetic susceptibility, single nucleotide polymorphisms, genome-wide association study, HLA region, gene-environment interaction, autoimmune demyelinating disease, pathogenesis, susceptibility genes, neuroimaging
- MeSH terms
- Animals, HLA Antigens, Humans, Multiple Sclerosis, Genome, Human, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.